Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Tuberculosis"" wg kryterium: Temat


Tytuł :
A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries.
Autorzy :
Chendi BH; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Molecular Biology and Human Genetics, Department of Science and Technology-National Research Foundation (DST-NRF) Centre of Excellence for Biomedical Tuberculosis Research, Faculty of Medicine and Health Sciences, South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.
Snyders CI; Division of Molecular Biology and Human Genetics, Department of Science and Technology-National Research Foundation (DST-NRF) Centre of Excellence for Biomedical Tuberculosis Research, Faculty of Medicine and Health Sciences, South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.
Tonby K; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Jenum S; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Kidd M; Department of Statistics and Actuarial Sciences, Centre for Statistical Consultation, Stellenbosch University, Cape Town, South Africa.
Walzl G; Division of Molecular Biology and Human Genetics, Department of Science and Technology-National Research Foundation (DST-NRF) Centre of Excellence for Biomedical Tuberculosis Research, Faculty of Medicine and Health Sciences, South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.
Chegou NN; Division of Molecular Biology and Human Genetics, Department of Science and Technology-National Research Foundation (DST-NRF) Centre of Excellence for Biomedical Tuberculosis Research, Faculty of Medicine and Health Sciences, South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.
Dyrhol-Riise AM; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Feb 24; Vol. 12, pp. 608846. Date of Electronic Publication: 2021 Feb 24 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mycobacterium tuberculosis*
Biomarkers/*blood
Tuberculosis/*blood
Tuberculosis/*diagnosis
Adult ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Norway/epidemiology ; ROC Curve ; South Africa/epidemiology ; Tuberculosis/epidemiology ; Tuberculosis/microbiology ; Tuberculosis, Pulmonary/blood ; Tuberculosis, Pulmonary/diagnosis ; Tuberculosis, Pulmonary/epidemiology ; Tuberculosis, Pulmonary/microbiology ; Young Adult
Czasopismo naukowe
Tytuł :
Comparison of chest computed tomography features between pulmonary tuberculosis patients with culture-positive and culture-negative sputum for non-mycobacteria: A retrospective observational study.
Autorzy :
Kan T; Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, Japan.
Komiya K; Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, Japan.; Department of Internal Medicine, National Hospital Organization Nishi-Beppu Hospital, 4548 Tsurumi, Beppu, Oita, Japan.
Yamasue M; Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, Japan.; Department of Internal Medicine, National Hospital Organization Nishi-Beppu Hospital, 4548 Tsurumi, Beppu, Oita, Japan.
Itai M; Department of Internal Medicine, National Hospital Organization Nishi-Beppu Hospital, 4548 Tsurumi, Beppu, Oita, Japan.
Tanaka A; Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, Japan.
Takeno Y; Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, Japan.; Department of Internal Medicine, National Hospital Organization Nishi-Beppu Hospital, 4548 Tsurumi, Beppu, Oita, Japan.
Takikawa S; Department of Internal Medicine, National Hospital Organization Nishi-Beppu Hospital, 4548 Tsurumi, Beppu, Oita, Japan.
Hiramatsu K; Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, Japan.
Kadota JI; Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, Japan.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Aug 06; Vol. 100 (31), pp. e26897.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Pneumonia, Bacterial*/diagnosis
Pneumonia, Bacterial*/drug therapy
Pneumonia, Bacterial*/epidemiology
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/epidemiology
Anti-Bacterial Agents/*therapeutic use
Lung/*diagnostic imaging
Sputum/*microbiology
Tomography, X-Ray Computed/*methods
Community-Acquired Infections/diagnosis ; Community-Acquired Infections/epidemiology ; Diagnosis, Differential ; Diagnostic Errors/prevention & control ; Female ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Mycobacterium tuberculosis/isolation & purification ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Diagnosing Pulmonary Tuberculosis by Using Sequence-Specific Purification of Urine Cell-Free DNA.
Autorzy :
Oreskovic A; Department of Bioengineering, University of Washington, Seattle, Washington, USA.
Panpradist N; Department of Bioengineering, University of Washington, Seattle, Washington, USA.
Marangu D; Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Ngwane MW; Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
Magcaba ZP; Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
Ngcobo S; Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
Ngcobo Z; Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.
Horne DJ; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Wilson DPK; Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.; Edendale Hospital, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Shapiro AE; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Drain PK; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Lutz BR; Department of Bioengineering, University of Washington, Seattle, Washington, USA.
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2021 Jul 19; Vol. 59 (8), pp. e0007421. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Cell-Free Nucleic Acids*
Tuberculosis, Pulmonary*/diagnosis
Cohort Studies ; HIV Infections ; Humans ; Mycobacterium tuberculosis/genetics ; Sensitivity and Specificity ; South Africa ; Sputum
Czasopismo naukowe
Tytuł :
Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA.
Autorzy :
MacLean E; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.; McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, Canada.
Nathavitharana RR; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2021 Jul 19; Vol. 59 (8), pp. e0070621. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell-Free Nucleic Acids*/urine
Tuberculosis*/diagnosis
HIV Infections ; Humans ; Mycobacterium tuberculosis/genetics ; Retrospective Studies ; Sensitivity and Specificity ; South Africa ; Sputum
Czasopismo naukowe
Tytuł :
T helper type 1 biased immune responses by PPE17 loaded core-shell alginate-chitosan nanoparticles after subcutaneous and intranasal administration.
Autorzy :
Najafi A; Clinical Microbiology Laboratory, Fatemieh Hospital, Hamedan University of Medical Science, Hamedan, Iran.
Ghazvini K; Department of Microbiology, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran.
Sankian M; Immunology Research Center, Bu Ali Research Institute, Mashhad University of Medical Science, Mashhad, Iran.
Gholami L; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Science, Mashhad, Iran.
Amini Y; Department of Microbiology, Faculty of Medicine, Zahedan University of Medical Science, Zahedan, Iran.
Zare S; Immunology Research Center, Bu Ali Research Institute, Mashhad University of Medical Science, Mashhad, Iran.
Khademi F; Department of Microbiology, School of Medicine, Ardabil University of Medical Science, Ardabil, Iran.
Tafaghodi M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Science, Mashhad, Iran. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Oct 01; Vol. 282, pp. 119806. Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, Bacterial*/chemistry
Antigens, Bacterial*/pharmacology
Drug Carriers*/chemistry
Drug Carriers*/pharmacology
Nanoparticles*/chemistry
Nanoparticles*/therapeutic use
Tuberculosis Vaccines*/chemistry
Tuberculosis Vaccines*/pharmacology
Th1 Cells/*immunology
Tuberculosis/*immunology
Administration, Intranasal ; Alginates/chemistry ; Alginates/pharmacology ; Animals ; Chitosan/chemistry ; Chitosan/pharmacology ; Injections, Subcutaneous ; Male ; Mice ; Mice, Inbred BALB C ; Th1 Cells/pathology ; Tuberculosis/prevention & control
Czasopismo naukowe
Tytuł :
Changes in health-related quality of life and the associated factors among Myanmar migrants with tuberculosis: a cohort study.
Autorzy :
Oo MM; Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. .
Boonathapat N; Mae Sot General Hospital, Mae Sot, Tak, Thailand.
Aung HKK; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Pungrassami P; Bureau of Tuberculosis, Ministry of Public Health, Nonthaburi, Thailand.
Liabsuetrakul T; Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Apr 21; Vol. 21 (1), pp. 377. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article
MeSH Terms :
Mycobacterium tuberculosis*
Antitubercular Agents/*therapeutic use
Quality of Life/*psychology
Transients and Migrants/*psychology
Tuberculosis, Pulmonary/*drug therapy
Tuberculosis, Pulmonary/*epidemiology
Adolescent ; Adult ; Female ; Follow-Up Studies ; Humans ; Longitudinal Studies ; Male ; Mental Health/trends ; Middle Aged ; Myanmar/epidemiology ; Prospective Studies ; Thailand/epidemiology ; Treatment Outcome ; Tuberculosis, Pulmonary/microbiology ; Tuberculosis, Pulmonary/psychology ; Young Adult
Czasopismo naukowe
Tytuł :
PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
Autorzy :
Grassi G; Laboratory of Cellular Immunology and Pharmacology, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Vanini V; Laboratory of Translational Research, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.; UOS Professioni Sanitarie Tecniche National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.
De Santis F; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Romagnoli A; Department of Epidemiology, Preclinical Research, and Advanced Diagnostics, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Aiello A; Laboratory of Translational Research, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Casetti R; Laboratory of Cellular Immunology and Pharmacology, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Cimini E; Laboratory of Cellular Immunology and Pharmacology, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Bordoni V; Laboratory of Cellular Immunology and Pharmacology, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Notari S; Laboratory of Cellular Immunology and Pharmacology, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Cuzzi G; Laboratory of Translational Research, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Mosti S; Respiratory Infectious Diseases Unit, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Gualano G; Respiratory Infectious Diseases Unit, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Palmieri F; Respiratory Infectious Diseases Unit, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Fraziano M; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Goletti D; Laboratory of Translational Research, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Agrati C; Laboratory of Cellular Immunology and Pharmacology, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Sacchi A; Laboratory of Cellular Immunology and Pharmacology, National Institute for infectious Diseases 'Lazzaro Spallanzani'-IRCCS, Rome, Italy.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Apr 26; Vol. 12, pp. 594376. Date of Electronic Publication: 2021 Apr 26 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Latent Tuberculosis*
Leukocyte Count*
Mycobacterium tuberculosis/*immunology
Myeloid-Derived Suppressor Cells/*immunology
Neutrophils/*immunology
Tuberculosis/*immunology
Tuberculosis/*microbiology
Adult ; Biomarkers ; Diagnosis, Differential ; Female ; Host-Pathogen Interactions/immunology ; Humans ; Male ; Middle Aged ; Monocytes/immunology ; Monocytes/metabolism ; Myeloid-Derived Suppressor Cells/metabolism ; Neutrophils/metabolism ; ROC Curve ; Severity of Illness Index ; Tuberculosis/diagnosis ; Young Adult
Czasopismo naukowe
Tytuł :
MPT64 assays for the rapid detection of Mycobacterium tuberculosis.
Autorzy :
Cao XJ; Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.; Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, 511436, China.
Li YP; Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.; Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, 511436, China.; Department of Clinical Medicine, The Second Clinical School of Guangzhou Medical University, Guangzhou, 511436, China.
Wang JY; Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.; Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, 511436, China.
Zhou J; Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.; Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, 511436, China.
Guo XG; Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China. .; Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, 511436, China. .; Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China. .; Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Apr 10; Vol. 21 (1), pp. 336. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Mycobacterium tuberculosis*/isolation & purification
Reagent Kits, Diagnostic*
Antigens, Bacterial/*immunology
Tuberculosis/*microbiology
Enzyme-Linked Immunosorbent Assay/methods ; Humans ; Immunoassay/methods ; Sensitivity and Specificity ; Tuberculosis/diagnosis
Czasopismo naukowe
Tytuł :
A novel, rapid (within hours) culture-free diagnostic method for detecting live Mycobacterium tuberculosis with high sensitivity.
Autorzy :
Wang WH; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 TzYou 1st Rd., Kaohsiung 80756, Taiwan.
Takeuchi R; R&D Department, TAUNS Laboratories, Inc., 761-1 Kamishima, Izunokuni, Shizuoka 410-2325, Japan.
Jain SH; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 TzYou 1st Rd., Kaohsiung 80756, Taiwan.
Jiang YH; R&D Department, TAUNS Laboratories, Inc., 761-1 Kamishima, Izunokuni, Shizuoka 410-2325, Japan.
Watanuki S; R&D Department, TAUNS Laboratories, Inc., 761-1 Kamishima, Izunokuni, Shizuoka 410-2325, Japan.
Ohtaki Y; R&D Department, TAUNS Laboratories, Inc., 761-1 Kamishima, Izunokuni, Shizuoka 410-2325, Japan.
Nakaishi K; R&D Headquarters, TAUNS Laboratories, Inc., 761-1 Kamishima, Izunokuni, Shizuoka 410-2325, Japan; Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan.
Watabe S; R&D Headquarters, TAUNS Laboratories, Inc., 761-1 Kamishima, Izunokuni, Shizuoka 410-2325, Japan; Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan.
Lu PL; Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 TzYou 1st Rd., Kaohsiung 80756, Taiwan; College of Medicine, Kaohsiung Medical University, 100 Shih-Chuan 1st Rd., Kaohsiung 80756, Taiwan. Electronic address: .
Ito E; Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan; Graduate Institute of Medicine, Kaohsiung Medical University, 100 Shih-Chuan 1st Rd., Kaohsiung 80756, Taiwan; Department of Biology, Waseda University, 2-2 Wakamatsucho, Shinjuku, Tokyo 162-8480, Japan. Electronic address: .
Pokaż więcej
Źródło :
EBioMedicine [EBioMedicine] 2020 Oct; Vol. 60, pp. 103007. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article
MeSH Terms :
Mycobacterium tuberculosis*/genetics
Nucleic Acid Amplification Techniques/*methods
Tuberculosis/*diagnosis
Tuberculosis/*microbiology
Antibiotics, Antitubercular/pharmacology ; Antibiotics, Antitubercular/therapeutic use ; Clinical Trials as Topic ; Enzyme-Linked Immunosorbent Assay ; Humans ; Nucleic Acid Amplification Techniques/standards ; Reproducibility of Results ; Sensitivity and Specificity ; Sputum/microbiology ; Tuberculosis/drug therapy ; Tuberculosis, Pulmonary/diagnosis
Czasopismo naukowe
Tytuł :
Challenges and opportunities to end tuberculosis in the COVID-19 era.
Autorzy :
Wingfield T; Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; Social Medicine, Infectious diseases, and Migration Group, Department of Global Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK. Electronic address: .
Karmadwala F; Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
MacPherson P; Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Millington KA; Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
Walker NF; Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Cuevas LE; Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; Zankli Research Centre, Bingham University, Nasarawa State, Nigeria.
Squire SB; Departments of Clinical Sciences and International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK; Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Pokaż więcej
Źródło :
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Jun; Vol. 9 (6), pp. 556-558. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
Disease Eradication*/methods
Disease Eradication*/organization & administration
Disease Eradication*/trends
Global Health*/economics
Global Health*/standards
Global Health*/trends
Health Services Accessibility*/organization & administration
Health Services Accessibility*/standards
Tuberculosis*/economics
Tuberculosis*/epidemiology
Tuberculosis*/therapy
Health Services Needs and Demand/*organization & administration
Humans ; Quality Improvement ; SARS-CoV-2 ; Social Determinants of Health/economics ; Social Determinants of Health/ethnology ; Social Determinants of Health/standards ; Tuberculosis, Multidrug-Resistant/epidemiology ; Tuberculosis, Multidrug-Resistant/therapy
Czasopismo naukowe
Tytuł :
Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease.
Autorzy :
Pollara G; University College London, London, UK. .
Turner CT; University College London, London, UK.
Rosenheim J; University College London, London, UK.
Chandran A; University College London, London, UK.
Bell LCK; University College London, London, UK.
Khan A; University College London, London, UK.
Patel A; University College London, London, UK.
Peralta LF; School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Folino A; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Akarca A; University College London, London, UK.
Venturini C; University College London, London, UK.
Baker T; University College London, London, UK.
Ecker S; University College London, London, UK.
Ricciardolo FLM; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Marafioti T; University College London, London, UK.
Ugarte-Gil C; School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Moore DAJ; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.; Laboratorio de Investigación de Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.
Chain BM; University College London, London, UK.
Tomlinson GS; University College London, London, UK. .
Noursadeghi M; University College London, London, UK. .
Pokaż więcej
Źródło :
Science translational medicine [Sci Transl Med] 2021 May 05; Vol. 13 (592).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Latent Tuberculosis*/diagnosis
Latent Tuberculosis*/immunology
Tuberculosis*/drug therapy
Tuberculosis*/immunology
Interleukin-17/*immunology
Humans ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł :
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China.
Autorzy :
Huang M; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Wang G; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Sun Q; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Jiang G; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Li W; Department of Emergency, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Ding Z; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jia H; Laboratory of Molecular Biology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Gao M; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Huang H; National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China. Electronic address: .
Li Q; Clinical Center on Tuberculosis Control, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China. Electronic address: .
Pokaż więcej
Źródło :
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2021 May; Vol. 100 (1), pp. 115306. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article
MeSH Terms :
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/genetics
Drug Resistance, Bacterial/*genetics
Molecular Diagnostic Techniques/*methods
Tuberculosis, Meningeal/*diagnosis
Adult ; Antibiotics, Antitubercular/pharmacology ; China ; DNA, Bacterial/cerebrospinal fluid ; Female ; Humans ; Male ; Middle Aged ; Nucleic Acid Amplification Techniques ; Rifampin/pharmacology ; Sensitivity and Specificity ; Tuberculosis, Meningeal/microbiology ; Young Adult
Czasopismo naukowe
Tytuł :
Risk factors associated with postoperative respiratory failure in tuberculous empyema patients.
Autorzy :
Ruan H; Cardiopulmonary Function Department.
Liu F; Science and Technology Office.
Gong C; Department of Thoracic Surgery.
Yang X; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, PR China.
Han M; Department of Thoracic Surgery.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jun 11; Vol. 100 (23), pp. e25754.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Loss, Surgical*/prevention & control
Blood Loss, Surgical*/statistics & numerical data
Postoperative Complications*/diagnosis
Postoperative Complications*/epidemiology
Postoperative Complications*/physiopathology
Respiratory Insufficiency*/diagnosis
Respiratory Insufficiency*/epidemiology
Respiratory Insufficiency*/etiology
Respiratory Insufficiency*/physiopathology
Risk Assessment*/methods
Risk Assessment*/statistics & numerical data
Tuberculosis, Pulmonary*/complications
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/surgery
Empyema, Tuberculous/*surgery
Thoracic Surgical Procedures/*adverse effects
Adult ; Carbon Dioxide/analysis ; China/epidemiology ; Empyema, Tuberculous/blood ; Empyema, Tuberculous/diagnosis ; Empyema, Tuberculous/epidemiology ; Female ; Humans ; Male ; Mycobacterium tuberculosis/isolation & purification ; Respiratory Function Tests/methods ; Respiratory Function Tests/statistics & numerical data ; Risk Factors ; Thoracic Surgical Procedures/methods
Czasopismo naukowe
Tytuł :
QuantiFERON-TB and tuberculin skin test in patients with active tuberculosis: the experience of a single medium-sized Italian University Hospital.
Autorzy :
Pasticci MB; Infectious Diseases Clinic, Department of Medicine, University of Perugia, Perugia, Italy.
Papalini C; Infectious Diseases Clinic, Department of Medicine, University of Perugia, Perugia, Italy.
Murgia N; Occupational Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
Papili R; Infectious Diseases Clinic, Department of Medicine, University of Perugia, Perugia, Italy.
Bucaneve G; Internal Medicine and Oncologic Sciences, Perugia Hospital, Perugia, Italy.
Malincarne L; Infectious Diseases Clinic, Department of Medicine, University of Perugia, Perugia, Italy.
Bozza S; Microbiology Section, Department of Medicine, University of Perugia, Perugia, Italy.
Francisci D; Infectious Diseases Clinic, Department of Medicine, University of Perugia, Perugia, Italy.
Cenci E; Microbiology Section, Department of Medicine, University of Perugia, Perugia, Italy.
Pokaż więcej
Źródło :
Le infezioni in medicina [Infez Med] 2021 Jun 01; Vol. 29 (2), pp. 229-235.
Typ publikacji :
Journal Article
MeSH Terms :
Latent Tuberculosis*/epidemiology
Tuberculin Test*/methods
Emigrants and Immigrants ; Humans ; Incidence ; Italy ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł :
Phenotype Definition for "Resisters" to Mycobacterium tuberculosis Infection in the Literature-A Review and Recommendations.
Autorzy :
Gutierrez J; Department of Population and Quantitative Health Science, Case Western Reserve University School of Medicine, Cleveland, OH, United States.
Kroon EE; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Möller M; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Stein CM; Department of Population and Quantitative Health Science, Case Western Reserve University School of Medicine, Cleveland, OH, United States.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Feb 25; Vol. 12, pp. 619988. Date of Electronic Publication: 2021 Feb 25 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Mycobacterium tuberculosis*/immunology
Phenotype*
Tuberculosis/*diagnosis
Tuberculosis/*microbiology
Global Health ; Humans ; Interferon-gamma Release Tests/methods ; Interferon-gamma Release Tests/standards ; Population Surveillance ; Tuberculin Test/methods ; Tuberculin Test/standards ; Tuberculosis/epidemiology ; Tuberculosis/immunology
Czasopismo naukowe
Tytuł :
The Use of Murine Infection Models to Investigate the Protective Role of TNF in Central Nervous System Tuberculosis.
Autorzy :
Hsu NJ; Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Jacobs M; Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. .; National Health Laboratory Service, Johannesburg, South Africa. .; Immunology of Infectious Disease Research Unit, University of Cape Town, Cape Town, South Africa. .
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2248, pp. 211-220.
Typ publikacji :
Journal Article
MeSH Terms :
Mycobacterium tuberculosis*/immunology
Tuberculosis, Central Nervous System/*metabolism
Tuberculosis, Central Nervous System/*microbiology
Tumor Necrosis Factor-alpha/*metabolism
Animals ; Bacterial Load ; Biomarkers ; Disease Models, Animal ; Disease Susceptibility ; Flow Cytometry ; Host-Pathogen Interactions ; Immunohistochemistry ; Mice ; Microscopy, Confocal ; Tuberculosis, Central Nervous System/drug therapy ; Tuberculosis, Central Nervous System/immunology
Czasopismo naukowe
Tytuł :
Microparticles in the pathogenesis of TB: Novel perspectives for diagnostic and therapy management of Mycobacterium tuberculosis infection.
Autorzy :
Dornelas Moreira J; Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Department of Pulmonary Immunology, The University of Texas Health Science Center at Tyler, Texas, United States. Electronic address: .
Rodrigues Silva H; Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Electronic address: .
de Paulo Coelho Peixoto de Toledo V; Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Electronic address: .
Mara Pinto Dabés Guimarães T; Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Microbial pathogenesis [Microb Pathog] 2020 Jul; Vol. 144, pp. 104176. Date of Electronic Publication: 2020 Mar 31.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/pathology
Antitubercular Agents/*therapeutic use
Cell-Derived Microparticles/*metabolism
Mycobacterium tuberculosis/*drug effects
Biomarkers/analysis ; Granuloma, Respiratory Tract/microbiology ; Granuloma, Respiratory Tract/pathology ; Humans ; Inflammation/pathology ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/pathology
Czasopismo naukowe
Tytuł :
Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis.
Autorzy :
Parums DV; Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2021 Aug 09; Vol. 27, pp. e934292. Date of Electronic Publication: 2021 Aug 09.
Typ publikacji :
Editorial
MeSH Terms :
Tuberculosis/*drug therapy
Tuberculosis, Multidrug-Resistant/*drug therapy
Tuberculosis, Pulmonary/*drug therapy
Antitubercular Agents/therapeutic use ; Clinical Protocols/standards ; Global Health ; Humans ; Mycobacterium tuberculosis/isolation & purification ; Tuberculosis/epidemiology ; Tuberculosis, Multidrug-Resistant/epidemiology ; Tuberculosis, Pulmonary/epidemiology ; World Health Organization
Opinia redakcyjna
Tytuł :
Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China.
Autorzy :
Liu Q; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, People's Republic of China.; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
You N; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, People's Republic of China.; The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Pan H; Department of Tuberculosis, The Third People's Hospital of Zhenjiang Affiliated to Jiangsu University, Zhenjiang, People's Republic of China.
Shen Y; Department of Epidemiology and Biostatistics, School of Public Health, University of Georgia, Athens, Georgia; and.
Lu P; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, People's Republic of China.
Wang J; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
Lu W; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, People's Republic of China.
Zhu L; Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, People's Republic of China.
Martinez L; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts.
Pokaż więcej
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Aug 01; Vol. 204 (3), pp. 347-356.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antitubercular Agents/*therapeutic use
Blood Glucose/*metabolism
Diabetes Mellitus/*epidemiology
Hyperglycemia/*epidemiology
Tuberculosis, Pulmonary/*drug therapy
Tuberculosis, Pulmonary/*metabolism
Adult ; China/epidemiology ; Cohort Studies ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/metabolism ; Female ; Humans ; Hyperglycemia/metabolism ; Hypoglycemic Agents/therapeutic use ; Male ; Metformin/therapeutic use ; Middle Aged ; Prospective Studies ; Tuberculosis/diagnosis ; Tuberculosis/drug therapy ; Tuberculosis/epidemiology ; Tuberculosis/metabolism ; Tuberculosis, Pulmonary/diagnosis ; Tuberculosis, Pulmonary/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies